NCT07086495

Brief Summary

This study aims to investigate the effect of aromatherapy using lavender oil on recovery speed and cardiovascular parameters in healthy athletes following aerobic exercise. Participants will perform aerobic exercise using the Bruce treadmill protocol and will be randomly assigned to either an aromatherapy group (inhaling lavender essential oil) or a control group (no aromatherapy). Heart rate, blood pressure, oxygen saturation, perceived exertion, and fatigue levels will be measured before and after exercise. The study seeks to determine whether aromatherapy contributes to faster physiological recovery and reduced fatigue following exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2024

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

9 months

First QC Date

July 18, 2025

Last Update Submit

July 18, 2025

Conditions

Keywords

AromatherapyPost-exercise recoveryComplementary therapyAthletic recovery

Outcome Measures

Primary Outcomes (2)

  • Heart Rate Recovery

    Heart rate was measured using a fingertip pulse oximeter. Participants remained seated and still during the measurements to ensure accuracy. The device provided real-time heart rate readings, recorded manually by the researcher.

    Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery

  • Systolic and Diastolic Blood Pressure

    Blood pressure was measured with a calibrated manual sphygmomanometer and a standard stethoscope using the auscultatory method. All measurements were taken from the left arm, with the participant in a seated position, after at least one minute of rest.

    Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery

Secondary Outcomes (3)

  • Oxygen Saturation (SpO₂)

    Baseline, immediately post-exercise, and at 5 and 15 minutes after recovery

  • Rating of Perceived Exertion

    Immediately post-exercise and after 15 minutes of recovery

  • Fatigue Severity Score

    Before exercise and after 15 minutes of recovery

Study Arms (3)

Aromatherapy Group

EXPERIMENTAL

Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After completing the exercise, they were taken to a separate room where a diffuser had been running for 15 minutes, containing 3 drops of lavender essential oil in 100 ml of water. They inhaled the aromatherapy during a 15-minute recovery period while cardiovascular parameters were monitored.

Other: Aromatherapy

Placebo Group

PLACEBO COMPARATOR

Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After exercise, they were taken to a separate room where a diffuser had been operating for 15 minutes with only 100 ml of plain water and no essential oils. They rested in this environment for 15 minutes, during which their cardiovascular parameters were monitored. This arm aimed to control for the effect of the diffuser itself without the therapeutic component of lavender oil.

Other: Placebo Diffuser (No Essential Oil)

Control Group

NO INTERVENTION

Participants in this group performed aerobic exercise using the Bruce treadmill protocol. After the exercise, they rested in a standard environment without exposure to any diffuser or aromatherapy. Their cardiovascular parameters were monitored during a 15-minute recovery period, serving as the baseline comparison for evaluating the effects of aromatherapy and placebo.

Interventions

Participants inhaled lavender essential oil (3 drops in 100 ml water) via diffuser during a 15-minute post-exercise recovery period following the Bruce treadmill protocol.

Aromatherapy Group

Participants were exposed to plain water vapor (100 ml of water without essential oil) via diffuser for 15 minutes during post-exercise recovery.

Placebo Group

Eligibility Criteria

Age12 Years - 14 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 12 and 14 years
  • Actively engaged in organized sports training (minimum 2 times per week)
  • Medically cleared to participate in moderate to vigorous physical activity
  • No known cardiovascular, respiratory, neurological, or metabolic conditions
  • Provided informed assent and obtained written parental/guardian consent

You may not qualify if:

  • Known allergy to lavender or any component of aromatherapy oils
  • Use of medications that may alter cardiovascular responses (e.g., beta-blockers)
  • History of cardiac disease, hypertension, or arrhythmia
  • Acute or recent musculoskeletal injury (within the last 3 months)
  • Acute upper respiratory tract infection during the assessment week
  • Inability to complete treadmill exercise testing or follow instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bezmialem Vakif University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Aromatherapy

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPhytotherapySensory Art TherapiesPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2025

First Posted

July 25, 2025

Study Start

January 10, 2024

Primary Completion

October 16, 2024

Study Completion

November 10, 2024

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to ethical considerations related to the age group of participants (12-14 years), the sensitivity of health-related information collected, and the limited scope of the study. The study involves minors, and although parental consent and participant assent were obtained, data sharing beyond the primary research team was not included in the consent process. Therefore, data will remain confidential and used solely for the purposes outlined in the approved study protocol.

Locations